Imperial College London

ProfessorEricAlton

Faculty of MedicineNational Heart & Lung Institute

Chair in Gene Therapy
 
 
 
//

Contact

 

+44 (0)20 7594 7937e.alton

 
 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Summary

Eric Alton is Professor of Gene Therapy and Respiratory Medicine, National Heart & Lung Institute, Imperial College London and Honorary Consultant Physician, Royal Brompton Hospital

Professor Alton was educated at Jesus College, Cambridge and Westminster Medical School and subsequently undertook six years of general medical training.  Over the last fifteen years, he has been involved in developing gene therapy for cystic fibrosis and angiogenesis, including three clinical trials.

Professor Alton coordinates the UK CF Gene Therapy Consortium which brings together the three centres in the UK (Edinburgh and Oxford Universities and Imperial College), including approximately 80 clinicians and scientists focused on this problem.

 

Publications

Journals

Alton EWFW, Beekman JM, Boyd AC, et al., Preparation for a first-in-man lentivirus trial in cystic fibrosis patients, Thorax, ISSN:1468-3296

Alton EWFW, Beekman JM, Boyd AC, et al., 2017, Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis, Thorax, Vol:72, ISSN:0040-6376, Pages:137-147

Alton EWFW, Boyd AC, Davies JC, et al., 2016, Genetic medicines for CF: Hype versus reality, Pediatric Pulmonology, Vol:51, ISSN:8755-6863, Pages:S5-S17

Bardin E, Bolt F, Cameron S, et al., 2016, METABOLOMIC CHARACTERIZATION OF PSEUDOMONAS AERUGINOSA ISOLATES FROM CYSTIC FIBROSIS PATIENTS USING RAPID EVAPORATIVE IONISATION MASS SPECTROMETRY, Pediatric Pulmonology, Vol:51, ISSN:8755-6863, Pages:312-313

Conference

Griesenbach U, Alton EWFW, Beekman JM, et al., 2016, Preparation for a First-in-Man Lentivirus Trial in Cystic Fibrosis Patients, 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), NATURE PUBLISHING GROUP, Pages:S214-S214, ISSN:1525-0016

More Publications